Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension | MicrobiomeTrials← Back to trialsNCT07700225
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07Est. Completion: 2032-12
Enrollment target: 1,000 participants Locations- Virginia Commonwealth University, Richmond, Virginia, United States
Other microbiome trials you might be interested in
Advanced/ Metastatic Her-2 Positive Breast Cancer
The aim of this trial is to study the safety, pharmacokinetics and preliminary efficacy of the HER2-targeted antibody-dr…
Shanghai, ChinaEst. completion Dec 31, 2028
Type 2 Diabetes
The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and …
Buffalo, United StatesCompleted Jun 30, 2025